Comparative Clinical Study To Evaluate The Efficacy Of Rohitaka Moola Kalka & Amalaki Beeja Kalka In The Management Of Shweta Pradara w s.r. To Leucorrhoea
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Improvement in amount of vaginal discharge
Study Overview
Brief Summary
The condition characterized with excessive secretion. Shweta pradara is not a disease but a symptom of various underlying health conditions. However, depending on the etiopathogenesis Shweta Pradara occurs due to vitiation of kapha which gets vitiated due to its own vitiating factor which further influences rasa dhatu along with other causative factors.There are several drugs for Shweta Pradara but here I have chosen comparative study between two single drugs i.e. Amalaki beeja kalka with madhu and sharkara and Rohitaka Moola Kalka with water which not only treats symptoms but also does samprapti bhanga.
Therefore I have selected 60 patients aged between 18-45 years, patients should be selected on the basis of inclusion and exclusion criteria. The trial will be of 3 consecutive months and follow up will be done after 3 days then after each months. Cured after 3 months patient gets 80-100percent relief from sign and symptoms.
Study Design
- Study Type
- Interventional
- Allocation
- Other
- Masking
- Not Applicable
Eligibility Criteria
- Ages
- 18.00 Year(s) to 45.00 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •Women in the age group of 18-45 years Patients complaining of white discharge per vaginum as a cardinal or associated symptom Patients willing for trial and ready to give written consent.
Exclusion Criteria
- •Patients suffering from STD’s Any other systemic disorder like Diabetes Mellitus Patients having any other gynecological problems like prolapse, fibroid, etc Pregnant women with profuse white discharge.
Outcomes
Primary Outcomes
Improvement in amount of vaginal discharge
Time Frame: 3 months | The trial drug will be given for 3 months with anupana and follow up will be done after cessation of medicine in 4 month
Secondary Outcomes
- Relief in Itching Lower backache and tenderness Per vagina(After analyzing all the parameters the result will)